FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and is designed to reduce intraocular pressure in a patient with glaucoma. Described are a biodegradable intraocular implant containing prostamides and prostamide compounds, as well as the method for its preparation.
EFFECT: group of inventions allows expanding the arsenal of therapeutic agents.
3 cl, 10 dwg, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
BIODEGRADABLE DRUG DELIVERY SYSTEMS FOR LONG-TERM RELEASE OF PROTEIN | 2013 |
|
RU2676102C2 |
METHODS FOR TREATING PATHOLOGY OF EYE BY MEANS OF IMPLANT WITH DURABLE DELIVERY OF DRUG SUBJECTS | 2014 |
|
RU2690841C1 |
INTRAOCULAR IMPLANTS CONTAINING PROSTAMIDE AND METHODS OF THEIR USE | 2014 |
|
RU2650614C2 |
METHOD OF TREATING ELEVATED INTRAOCULAR PRESSURE USING INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEM | 2014 |
|
RU2664686C2 |
INTRAOCULAR SYSTEMS OF SUSTAINED-RELEASE DRUG DELIVERY AND METHOD OF TREATING OPHTHALMIC DISEASES | 2010 |
|
RU2532333C2 |
REDUCTION OF INTRAOCULAR PRESSURE BY INTRACHAMBER BIMATOPROST IMPLANTS | 2011 |
|
RU2586298C2 |
IMPLANT FOR PROLONGED DRUG DELIVERY | 2014 |
|
RU2641021C2 |
INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
INTRACHAMBER IMPLANTS WITH PROLONGED RELEASE OF THERAPEUTIC AGENT | 2011 |
|
RU2565445C2 |
EYE IMPLANTAT PREPARED BY DOUBLE EXTRUSION METHOD | 2005 |
|
RU2389479C2 |
Authors
Dates
2018-09-11—Published
2014-03-14—Filed